Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents July 06, 2021; Volume Issue Supplement 2

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Antwi, Kwadwo

    1. You have access
      Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
      Damian Wild, Kwadwo Antwi, Melpomeni Fani and Emanuel R. Christ
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 44S-50S; DOI: https://doi.org/10.2967/jnumed.120.246009
  2. Avram, Anca

    1. You have access
      Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
      Luca Giovanella, Anca Avram and Jerome Clerc
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 20S-25S; DOI: https://doi.org/10.2967/jnumed.120.246017
  3. Avram, Anca M.

    1. You have access
      A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses
      Anders Sundin, Elif Hindié, Anca M. Avram, Antoine Tabarin, Karel Pacak and David Taïeb
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 26S-33S; DOI: https://doi.org/10.2967/jnumed.120.246066
    2. Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm
      You have access
      Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm
      Elif Hindié, Paul Schwartz, Anca M. Avram, Alessio Imperiale, Frederic Sebag and David Taïeb
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 3S-12S; DOI: https://doi.org/10.2967/jnumed.120.245993
  4. Bashari, Waiel A.

    1. You have access
      Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas
      Waiel A. Bashari, Russell Senanayake, James MacFarlane, Daniel Gillett, Andrew S. Powlson, Angelos Kolias, Richard J. Mannion, Olympia Koulouri and Mark Gurnell
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 57S-62S; DOI: https://doi.org/10.2967/jnumed.120.251546
  5. Becker, Susan A.

    1. You have access
      18F-6-Fluoro-l-Dopa PET/CT Imaging of Congenital Hyperinsulinism
      Lisa J. States, J. Christopher Davis, Steven M. Hamel, Susan A. Becker and Hongming Zhuang
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 51S-56S; DOI: https://doi.org/10.2967/jnumed.120.246033
  6. Bernet, Victor J.

    1. You have access
      Update on the Evaluation of Thyroid Nodules
      Victor J. Bernet and Ana-Maria Chindris
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.120.246025
  7. Chindris, Ana-Maria

    1. You have access
      Update on the Evaluation of Thyroid Nodules
      Victor J. Bernet and Ana-Maria Chindris
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.120.246025
  8. Christ, Emanuel R.

    1. You have access
      Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
      Damian Wild, Kwadwo Antwi, Melpomeni Fani and Emanuel R. Christ
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 44S-50S; DOI: https://doi.org/10.2967/jnumed.120.246009
  9. Clerc, Jerome

    1. You have access
      Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
      Luca Giovanella, Anca Avram and Jerome Clerc
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 20S-25S; DOI: https://doi.org/10.2967/jnumed.120.246017
  10. Crandall, John P.

    1. You have access
      Perspectives on Brown Adipose Tissue Imaging: Insights from Preclinical and Clinical Observations from the Last and Current Century
      John P. Crandall and Richard L. Wahl
      Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 34S-43S; DOI: https://doi.org/10.2967/jnumed.120.246991
« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (Supplement 2)
Journal of Nuclear Medicine
Vol. 62, Issue Supplement 2
July 6, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire